PCSA
Processa Pharmaceuticals, Inc.
$2.17
-8.44%
$6.0M
No data for this timeframe.
Vol
Market Cap$6.0M
Cap SizeNano Cap
Inst. Holders5 funds
Inst. Value$59.5K
Inst. Activity2 buys / 0 sells
Insider Activity34B / 0S
Insider Net $$170.2K
SEC Reports7
Recent Activity
Jun 1, 2026
SEC
Two C-suite insiders at Processa Pharmaceuticals made open-market purchases totaling ~$9K on May 29, 2026, at $2.57/shar
CLUSTER — Impact 4/10
May 29, 2026
Insider
Guy Wendy bought 1,829 shares
Chief Administrative Officer @ $2.57 ($4.7K)
May 29, 2026
Insider
Lin Patrick bought 1,582 shares
Chief Business - Strategy Off @ $2.57 ($4.1K)
May 29, 2026
Insider
Ng George K bought 2,129 shares
Chief Executive Officer @ $2.57 ($5.5K)
May 19, 2026
SEC
Four C-suite insiders at Processa Pharmaceuticals (PCSA) collectively purchased $19K worth of shares on May 15, 2026, at
CLUSTER — Impact 5/10
May 19, 2026
SEC
Six PCSA insiders, including the CEO, CFO, and four other C-suite officers, made clustered open-market purchases totalin
CLUSTER — Impact 5/10
Inst.
VANGUARD GROUP INC — DOUBLED
288,212 shares ($55.3K)
Inst.
BANK OF AMERICA CORP — DOUBLED
378 shares ($72.00)
Analyst Ratings
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Sep 2, 2025 | HC Wainwright & Co. | MAINTAIN | Buy → Buy |
| Jun 30, 2025 | HC Wainwright & Co. | MAINTAIN | Buy → Buy |
| Dec 5, 2024 | HC Wainwright & Co. | REITERATE | Buy → Buy |
| Aug 20, 2024 | HC Wainwright & Co. | REITERATE | Buy → Buy |
| Aug 19, 2024 | HC Wainwright & Co. | MAINTAIN | Buy → Buy |
Latest Reports
BULLISH
CLUSTER
4/10
Two C-suite insiders at Processa Pharmaceuticals made open-market purchases totaling ~$9K on May 29, 2026, at $2.57/shar
Jun 1, 2026
BULLISH
CLUSTER
5/10
Four C-suite insiders at Processa Pharmaceuticals (PCSA) collectively purchased $19K worth of shares on May 15, 2026, at
May 19, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $32.1K | — |
| VANGUARD FIDUCIARY TRUST CO | $27.4K | — |
| CITIGROUP INC | $35.00 | — |
| JONES FINANCIAL COMPANIES LLLP | $17.00 | — |
| WELLS FARGO & COMPANY/MN | $15.00 | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 29, 2026 | Guy Wendy | BUY | $4.7K |
| May 29, 2026 | Lin Patrick | BUY | $4.1K |
| May 29, 2026 | Ng George | BUY | $5.5K |
| May 29, 2026 | SKIBSTED RUSSELL | BUY | $5.9K |
| May 29, 2026 | Young David | BUY | $4.6K |
5 institutional holders with $59.5K total value (23,613 shares) as of 2026-Q1. Top holders: VANGUARD, VANGUARD, CITIGROUP.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 12,729 | $32.1K | 53.9% | — |
| 2 | VANGUARD FIDUCIARY TRUST CO | 10,857 | $27.4K | 46.0% | — |
| 3 | CITIGROUP INC | 14 | $35.00 | 0.1% | — |
| 4 | JONES FINANCIAL COMPANIES LLLP | 7 | $17.00 | 0.0% | — |
| 5 | WELLS FARGO & COMPANY/MN | 6 | $15.00 | 0.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | DOUBLED | 24,433 | 288,212 | +1079.6% | $55.3K | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 108 | 378 | +250.0% | $72.00 | 2025-Q3 |
| UBS Group AG | DOUBLED | 56 | 64,612 | +115278.6% | $13.2K | 2025-Q2 |
| UBS Group AG | NEAR_EXIT | 7,908 | 56 | -99.3% | $21.00 | 2025-Q1 |
| BANK OF AMERICA CORP /DE/ | ADD | 25 | 37 | +48.0% | $14.00 | 2025-Q1 |
| UBS Group AG | DOUBLED | 521 | 7,908 | +1417.9% | $7.0K | 2024-Q4 |
9 unique insiders with 38 transactions. Net insider value: $170.2K ($170.2K bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 29, 2026 | Guy Wendy | Chief Administrative Officer | BUY | 1,829 | $2.57 | $4.7K |
| May 29, 2026 | Lin Patrick | Chief Business - Strategy Off | BUY | 1,582 | $2.57 | $4.1K |
| May 29, 2026 | Ng George K | Chief Executive Officer | BUY | 2,129 | $2.57 | $5.5K |
| May 29, 2026 | SKIBSTED RUSSELL | Chief Financial Officer | BUY | 2,292 | $2.57 | $5.9K |
| May 29, 2026 | Young David | Pres. Research & Development | BUY | 1,786 | $2.57 | $4.6K |
| May 15, 2026 | Guy Wendy | Chief Administrative Officer | BUY | 1,583 | $2.97 | $4.7K |
| May 15, 2026 | SKIBSTED RUSSELL | Chief Financial Officer | BUY | 1,984 | $2.97 | $5.9K |
| May 15, 2026 | Lin Patrick | Chief Business - Strategy Off | BUY | 1,369 | $2.97 | $4.1K |
| May 15, 2026 | Young David | Pres. Research & Development | BUY | 1,545 | $2.97 | $4.6K |
| May 15, 2026 | Ng George K | Chief Executive Officer | BUY | 1,843 | $2.97 | $5.5K |
| Apr 30, 2026 | Bigora Sian | Chief Development Officer | BUY | 1,971 | $2.71 | $5.3K |
| Apr 30, 2026 | Bigora Sian | Chief Development Officer | BUY | 1,986 | $2.69 | $5.3K |
| Apr 30, 2026 | Ng George K | Chief Executive Officer | BUY | 2,034 | $2.69 | $5.5K |
| Apr 30, 2026 | Young David | Pres. Research & Development | BUY | 1,706 | $2.69 | $4.6K |
| Apr 30, 2026 | Guy Wendy | Chief Administrative Officer | BUY | 1,748 | $2.69 | $4.7K |
| Apr 30, 2026 | SKIBSTED RUSSELL | Chief Financial Officer | BUY | 2,190 | $2.69 | $5.9K |
| Apr 15, 2026 | Ng George K | Chief Executive Officer | BUY | 1,843 | $2.97 | $5.5K |
| Apr 15, 2026 | Young David | Pres. Research & Development | BUY | 1,545 | $2.97 | $4.6K |
| Apr 15, 2026 | SKIBSTED RUSSELL | Chief Financial Officer | BUY | 1,984 | $2.97 | $5.9K |
| Apr 15, 2026 | Guy Wendy | Chief Administrative Officer | BUY | 1,583 | $2.97 | $4.7K |
| Apr 15, 2026 | Lin Patrick | Chief Business - Strategy Off | BUY | 1,369 | $2.97 | $4.1K |
| Apr 15, 2026 | Bigora Sian | Chief Development Officer | BUY | 1,799 | $2.97 | $5.3K |
| Apr 15, 2026 | Ng George K | Chief Executive Officer | BUY | 1,843 | $2.97 | $5.5K |
| Apr 15, 2026 | Ng George K | Chief Executive Officer | BUY | 1,843 | $2.97 | $5.5K |
| Mar 31, 2026 | Young David | Pres. Research & Development | BUY | 1,810 | $2.54 | $4.6K |
| Mar 31, 2026 | Ng George K | Chief Executive Officer | BUY | 2,136 | $2.54 | $5.4K |
| Mar 31, 2026 | Pannu Geraldine | Director | BUY | 2,072 | $2.54 | $5.3K |
| Mar 31, 2026 | Baluch Khoso | Director | BUY | 2,269 | $2.54 | $5.8K |
| Mar 31, 2026 | Bigora Sian | Chief Development Officer | BUY | 2,107 | $2.54 | $5.3K |
| Mar 31, 2026 | Lin Patrick | Chief Business - Strategy Off | BUY | 1,603 | $2.54 | $4.1K |
| Mar 31, 2026 | Guy Wendy | Chief Administrative Officer | BUY | 1,854 | $2.54 | $4.7K |
| Mar 31, 2026 | SKIBSTED RUSSELL | Chief Financial Officer | BUY | 2,324 | $2.54 | $5.9K |
| Mar 31, 2026 | Neal James R | Director | BUY | 789 | $2.54 | $2.0K |
| Mar 31, 2026 | Ng George K | Chief Executive Officer | BUY | 2,136 | $2.54 | $5.4K |
| Jan 1, 2026 | Young David | Pres. Research & Development | EXERCISE | 49 | — | — |
| Jan 1, 2026 | Lin Patrick | Chief Business - Strategy Off | EXERCISE | 193 | — | — |
| Jan 1, 2026 | Bigora Sian | Chief Development Officer | EXERCISE | 249 | — | — |
| Jan 1, 2026 | Guy Wendy | Chief Administrative Officer | EXERCISE | 193 | — | — |
7 SEC filing reports analyzed. Sentiment: 7 bullish, 0 bearish, 0 mixed, 0 neutral. Avg impact: 5.0/10.
BULLISH
CLUSTER
4/10
Two C-suite insiders at Processa Pharmaceuticals made open-market purchases totaling ~$9K on May 29,
Jun 1, 2026
BULLISH
CLUSTER
5/10
Four C-suite insiders at Processa Pharmaceuticals (PCSA) collectively purchased $19K worth of shares
May 19, 2026
BULLISH
CLUSTER
5/10
Six PCSA insiders, including the CEO, CFO, and four other C-suite officers, made clustered open-mark
May 19, 2026
BULLISH
CLUSTER
4/10
Three C-suite executives at Processa Pharmaceuticals (CEO, CAO, CDO) purchased a combined ~$15.5K of
May 1, 2026
BULLISH
CLUSTER
6/10
Nine insiders at Processa Pharmaceuticals, including the CEO, CFO, and multiple directors, made open
Apr 30, 2026
BULLISH
CLUSTER
5/10
Two corporate insiders at Processa Pharmaceuticals — the CFO and Chief Development Officer — made op
Apr 17, 2026
BULLISH
CLUSTER
6/10
Multiple insiders at Processa Pharmaceuticals, including the CEO, CFO, and other C-suite executives,
Apr 1, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Sep 2025): 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q 2026-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2025-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
2 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Sep 2, 2025 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| Jun 30, 2025 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| Dec 5, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Aug 20, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Aug 19, 2024 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| Aug 1, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Jun 12, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| May 13, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Apr 25, 2024 | HC Wainwright & Co. | INITIATE | — | Buy |
| Mar 6, 2024 | Benchmark | REITERATE | Speculative Buy | Speculative Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| May 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Apr 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Mar 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Feb 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% | |
| Jan 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 6, 2026
earnings_calendar
PCSA Q1 2026 Earnings Scheduled — 2026-05-06
Mar 18, 2026
earnings_calendar
PCSA Q4 2025 Earnings After Market Close — 2026-03-18